Most beta blockers have names that end with which suffix?

Beta blockers are a class of medications primarily used to manage cardiovascular conditions, including hypertension and arrhythmias. The suffix that many beta blockers share is "-lol." This naming convention helps to identify the drug class, making it easier for healthcare professionals to recognize that a medication is a beta receptor antagonist.

For instance, well-known beta blockers such as metoprolol, atenolol, and propranolol end with "-lol." This consistent suffix aids in the classification of these drugs, which work by blocking beta-adrenergic receptors, ultimately leading to a reduction in heart rate and blood pressure.

The other suffixes mentioned do not relate to beta blockers. For example, "-sartan" is associated with angiotensin receptor blockers (ARBs), used in hypertension and heart failure treatment. The "-pril" suffix refers to ACE inhibitors, which also manage high blood pressure but do so through a different mechanism. Lastly, the "-ine" suffix is often found in a variety of other drug classes, including antihistamines and some stimulants, and does not denote beta blockers specifically.